What is it about?
Evaluate the expression of HIF-1α and VEGF in feline mammary carcinomas and analyze their correlations with clinical and pathological factors.
Featured Image
Photo by Kate Stone Matheson on Unsplash
Why is it important?
This study suggests that the overexpression of HIF-1α may indicate poor prognosis/overall survival rate in cats with FMGCs. Developing compounds that inhibit HIF-1α may be a potential approach to FMGC treatment.
Perspectives
This study provides 1) a direction of drug development for treating feline mammary carcinomas and 2) new prognostic factors to evaluate the prognosis in cat with mammary carcinomas
Dr. Wen-Ta Li
Fishhead Labs LLC
Read the Original
This page is a summary of: Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes, BMC Veterinary Research, May 2020, Springer Science + Business Media,
DOI: 10.1186/s12917-020-02338-y.
You can read the full text:
Resources
Contributors
The following have contributed to this page
